Cardinal Capital Management Novartis Ag Transaction History
Cardinal Capital Management
- $708 Million
- Q3 2025
A detailed history of Cardinal Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Cardinal Capital Management holds 49,561 shares of NVS stock, worth $6.52 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
49,561
Previous 49,013
1.12%
Holding current value
$6.52 Million
Previous $5.93 Million
7.15%
% of portfolio
0.9%
Previous 0.89%
Shares
37 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...